Geron Corporation

Healthcare

NASDAQ:GERN · NASDAQ Global Select

Market Cap $808.32M Beta 0.60 P/E (TTM) -12.3

$1.26 +4.07%

+$0.05 today

52W Low $1.04High $2.01

Vol 19.57M · Avg 16.28M

EPS (TTM) -$0.10Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-11.27%

Period High

$1.95

Period Low

$1.07

Latest

$1.26

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Day One Biopharmaceuticals, Inc.

DAWN

$2.22B

Tyra Biosciences, Inc.

NASDAQ:TYRA

$1.67B

Vir Biotechnology, Inc.

NASDAQ:VIR

$1.53B

ArriVent BioPharma, Inc. Common Stock

NASDAQ:AVBP

$1.49B

Savara Inc.

NASDAQ:SVRA

$1.11B

Replimune Group, Inc.

NASDAQ:REPL

$839.76M

Valneva SE

NASDAQ:VALN

$507.30M

Rezolute, Inc.

NASDAQ:RZLT

$488.68M

Arvinas, Inc.

NASDAQ:ARVN

$486.89M

LENZ Therapeutics, Inc.

NASDAQ:LENZ

$183.95M

What is the latest GERN filing?

The latest filing shown is 8-K dated May 27, 2026.

How many recent filings does GERN have?

Intrinsic Alpha currently shows 20 recent filings for GERN.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.